SCHEMBL19937255

SCHEMBL19937255

c1ccc(-c2ccc(-c3cc(-c4ccccc4)nc(-c4cc(-c5cc6ccccc6c6ccccc56)cc(-c5ccnc6c5sc5ccccc56)c4)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.36
▸ LIMK1 P53667 3/20 0.36
▸ TOP1 P11387 4/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ NTSR1 P30989 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ KRAS P01116 1/20 0.32
▸ ACACA Q13085 2/20 0.31
▸ EGFR P00533 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21263422 0.98 CYP11B1 (0.38) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL21263426 0.97 CYP11B1 (0.36) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL21263427 0.97 CYP11B1 (0.36) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL19937171 0.96 CYP11B1 (0.35) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL19937310 0.95 CYP11B1 (0.37) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL19937231 0.94 CYP1A1 (0.39) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL19937170 0.94 CYP11B1 (0.35) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL21263482 0.94 CYP11B1 (0.38) CYP11B1LIMK1CDK5CDK5R1MAPT
SCHEMBL19937235 0.92 CYP1A1 (0.36) CYP11B1LIMK1TOP1MEN1KMT2A
SCHEMBL21263485 0.92 CYP11B1 (0.35) CYP11B1LIMK1TOP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190248804-A1 SPECIFICALLY SUBSTITUTED AZA-DIBENZOFURANS AND AZA-DIBENZOTHIOPHENES FOR ORGANIC ELECTRONIC DEVICES IDEMITSU KOSAN CO., LTD. (JP) 2019-08-15 — — US disclosed
WO-2018043761-A1 SPECIFICALLY SUBSTITUTED AZA-DIBENZOFURANS AND AZA-DIBENZOTHIOPHENES FOR ORGANIC ELECTRONIC DEVICES IDEMITSU KOSAN CO.,LTD. (JP) 2018-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190248804-A1 SPECIFICALLY SUBSTITUTED AZA-DIBENZOFURANS AND AZA-DIBENZOTHIOPHENES FOR ORGANIC ELECTRONIC DEVICES CDY1; CDY1B, CDYL, CBX8 CYP11B1 2810/4885LIMK1 3482/4885TOP1 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback